All In MedTech

Device Trial Radar · NCT00736840

BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis

Pivotal Study to Evaluate the Efficacy and Safety of the BreathID® System for Detection of Cirrhosis Using the ¹³C-methacetin Breath Test(MBT)

Last checked: Nov 20, 2026Latest source record: Jan 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

414

Actual

Start

Aug 2008

Primary completion

Sep 2009

Study completion Sep 2009

Sponsor

Lead sponsor
Meridian Bioscience, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 18, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
Single (investigator)
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial is a pivotal trial to validate the use of a 13 C labeled substrate called methacetin and the BreathID automatic breath testing system, for determination of cirrhosis in patients with chronic liver disease.

Conditions

  • Chronic Liver Disease

Interventions

  • c13 methacetin solution with breath analyzerDevice

    Carbon 13 methacetin 75mg dissolved in 150 ml is given to the subject and metabolism is measured by a breath analyzer after decomposed by the liver

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects With Likelihood of Cirrhosis Based on "Hepatic Impairment Score" (HIS)Time frame: Study day 1 after a 1 hour test

Locations

11 sites in 2 countries. Site status is shown where the registry gives one.

  • Cedars Sinai Medical Center

    Los Angeles, California

  • Henry Ford Health Sytem

    Detroit, Michigan

  • Cleveland Clinic

    Cleveland, Ohio

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.